Phase I/II Study of LY231514 Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
Phase I/II Study of LY231514 Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
To investigate efficacy and safety of pemetrexed combined with cisplatin for chemo-naive patients with Malignant Pleural Mesothelioma.
Inclusion Criteria:
Exclusion Criteria:
Aichi, Japan
Ehime, Japan
Fukuoka, Japan
Hokkaido, Japan
Okayama, Japan
Osaka, Japan